Study of the Oral Treatment MTR-601 in Cervical Dystonia

PHASE2RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

February 28, 2025

Primary Completion Date

July 8, 2026

Study Completion Date

August 3, 2026

Conditions
Cervical Dystonia
Interventions
DRUG

MTR-601

Capsule

DRUG

Placebo

Capsule

Trial Locations (17)

10029

RECRUITING

Icahn School of Medicine at Mount Sinai, New York

12208

RECRUITING

Albany Medical Center Neurosciences Institute, Albany

26506

RECRUITING

West Virginia University Medicine, Morgantown

30329

RECRUITING

Emory University, Atlanta

32825

RECRUITING

Neurology One, Orlando

33613

RECRUITING

University of South Florida, Tampa

37232

RECRUITING

Vanderbilt Neurology, The Vanderbilt Clinic, Nashville

48334

RECRUITING

Quest Research Institute, Farmington Hills

48824

RECRUITING

Michigan State University, Department of Neurology, East Lansing

60612

RECRUITING

Rush University Medical Center, Chicago

80113

RECRUITING

CenExel Rocky Mountain Clinical Research, Englewood

85032

RECRUITING

Arizona Neuroscience Research, LLC, Phoenix

87106

RECRUITING

University of New Mexico, The Nene and Jamie Koch Comprehensive Movement Disorder Clinic, Albuquerque

90033

RECRUITING

Keck Medicine of University of Southern California, Los Angeles

92708

RECRUITING

The Parkinson's and Movement Disorder Institute, Fountain Valley

99201

RECRUITING

Kingfisher Cooperative, LLC, Spokane

02114

RECRUITING

Massachusetts General Hospital, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Motric Bio

INDUSTRY

NCT06830642 - Study of the Oral Treatment MTR-601 in Cervical Dystonia | Biotech Hunter | Biotech Hunter